A novel Phase II single-arm hybrid design to minimize trial duration and enhance subsequent Phase III trial success rate
© 2024 Informa UK Limited, trading as Taylor & Francis Group.
Détails bibliographiques
| Publié dans: | Journal of applied statistics. - 1991. - 52(2025), 3 vom: 01., Seite 578-594
|
|---|
| Auteur principal: |
Lu, Jun
(Auteur) |
|---|
| Autres auteurs: |
Zhang, Yuzi,
Cui, Ying,
Peng, Limin,
Chen, Zhengjia |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | English |
|---|
| Publié: |
2025
|
|---|
| Accès à la collection: | Journal of applied statistics
|
|---|
| Sujets: | Journal Article
ClinicalTrials.gov identifier: NCT02492568.
Double screening
Phase II hybrid design
cost and length of trial
percent of tumor size change
success rate of Phase III trials
survival |
|---|